VOBILON

Vobilon (Capsules)
(Ginkgo Biloba)



CONTENT:
Capsules. Capsule contains dry standardized extract of ginkgo biloba leaves 80 mg.
 
PHARMACOLOGICAL PROPERTIES:
Vobilon is a herbal drug, contains gingko biloba extract, improving cerebral and peripheral circulation. Biologically active substances of the extract (flavonoid glycosides, terpenic lactones) promote fortification and increase of elasticity of vessel wall, improve rheological properties of blood. The drug administration leads to improvement of microcirculation, enhances brain and peripheral tissues supply with oxygen and glucose. It normalizes metabolism in cells, prevents erythrocytes aggregation, inhibits platelet aggregation. It dilates arterioles, increases vein tone.
Pharmacokinetic parameters of ginkgo biloba are hardly estimated due to multicomponent composition of the extract.
 
THERAPEUTIC INDICATIONS:
- dyscirculatory encephalopathy of different etiology (stroke, craniocerebral trauma, old age), accompanied by decrease of attention and/or memory, disturbance of intellectual facilities, anxious feeling, fear, sleep disturbances;
- dementia, including in Alzheimer's disease;
- for memory and attention improvement at persons of young age;
- disturbances of peripheral circulation and microcirculation (including arteriopathy of lower limbs), Raynaud's syndrome;
- neuronal impairments with dizziness, tinnitus, hypacusia);
- senile degeneration of macula;
- diabetic retinopathy.
 
CONTRAINDICATIONS:
- decreased coagulation;
- erosive gastritis;
- stomach and duodenum ulcer;
- acute strokes;
- acute cardiac infarction;
- arterial hypotension;
- childhood;
- hypersensitivity to the components of drug.
 
SIDE EFFECTS:
Vobilon is well tolerated, adverse reactions occur rarely.
From digestive system: dyspeptic disturbances, nausea.
From central nervous system: headache, dizziness.
 
DOSAGE AND ADMINISTRATION:
Vobilon is administered orally during or after meal. Capsules should be swallowed as a whole, washing down with small amount of water.
At dementia: 1 capsule 3 times per day.
At disturbances of peripheral circulation and microcirculation: 1 - 2 capsules 3 times per day.
At dizziness, tinnitus, sleep disturbances: 1 capsule 2 times per day (in the morning and in the evening).
In other cases: 1 capsule 2 times per day.
The course of treatment is not less than 3 months. The first signs of improvement usually occur after 1 month.
 
OVERDOSAGE:
The cases of drug Vobilon overdosage are not reported at the present time.
 
INFLUENCE ON ABILITY FOR DRIVING AND OPERATING WITH MECHANISMS:
Vobilon does not influence the ability for driving a vehicle and operating with other technical facilities, demanding high reaction speed.
 
APPLICATION AT PREGNANCY AND LACTATION:
The drug is not recommended at pregnancy and lactation period.
 
PACKAGING:
10 capsules in blister.
3 blisters with packaging leaflet in carton box.